Biology Reference
In-Depth Information
from ischemic damage. J Cereb Blood Flow
Metab 21:1303-1309
169. Kelly S, Zhanf ZJ, Zhao H, Xu L, Giffard RG,
Sapolsky RM, Yenari MA, Steinberg GK
(2002) Gene transfer of HSP72 protects
cornu ammonis 1 region of the hippocampus
neurons from global ischemia: infl uence of
Bcl-2. Ann Neurol 52:160-167
170. Lim MC, Brooke SM, Sapolsky RM (2003)
gp120 neurotoxicity fails to induce heat shock
defenses, while the over expression of hsp70 pro-
tects against gp120. Brain Res Bull 61:183-188
171. Ho DY, Mocarski ES, Sapolsky RM (1993)
Altering central nervous system physiology
with a defective herpes simplex virus vector
expressing the glucose transporter gene. Proc
Natl Acad Sci USA 90:3655-3659
172. Lawrence MS, Ho DY, Dash R, Sapolsky RM
(1995) Herpes simplex virus vectors overex-
pressing the glucose transporter gene protect
against seizure-induced neuron loss. Proc
Natl Acad Sci USA 92:7247-7251
173. Ho DY, Saydam TC, Fink SL, Lawrence MS,
Sapolsky RM (1995) Defective herpes simplex
virus vectors expressing the rat brain glucose
transporter protect cultured neurons from
necrotic insults. J Neurochem 65:842-850
174. Meier TJ, Ho DY, Park TS, Sapolsky RM
(1998) Gene transfer of calbindin D28k
cDNA via herpes simplex virus amplicon vec-
tor decreases cytoplasmic calcium ion response
and enhances neuronal survival following glu-
tamatergic challenge but not following cya-
nide. J Neurochem 71:1013-1023
175. Phillips RG, Meier TJ, Giuli LC, McLaughlin
JR, Ho DY, Sapolsky RM (1999) Calbindin
D28K gene transfer via herpes simplex virus
amplicon vector decreases hippocampal
damage in vivo following neurotoxic insults.
J Neurochem 73:1200-1205
176. Wang H, Cheng E, Brooke S, Chang P,
Sapolsky R (2003) Over-expression of anti-
oxidant enzymes protects cultured hippocam-
pal and cortical neurons from necrotic insults.
J Neurochem 87:1527-1534
177. Zemlyak I, Nimon V, Brooke S, Moore T,
McLaughlin J, Sapolsky R (2006) Gene ther-
apy in the nervous system with superoxide
dismutase. Brain Res 1088:12-18
178. Lamigeon C, Prod'Hon C, De Frias V,
Michoudet C, Jacquemont B (2003)
Enhancement of neuronal protection from
oxidative stress by glutamic acid decarboxyl-
ase delivery with a defective herpes simplex
virus vector. Exp Neurol 184:381-392
179. Rainov NG, Sena-Esteves M, Fraefel C,
Dobberstein KU, Chiocca EA, Breakefi eld
XO (1998) A chimeric fusion protein of cyto-
chrome CYP4B1 and green fl uorescent pro-
tein for detection of pro-drug activating gene
delivery and for gene therapy in malignant
glioma. Adv Exp Med Biol 451:393-403
180. Jacobs AH, Winkeler A, Hartung M, Slack M,
Dittmar C, Kummer C, Knoess C, Galldiks
N, Vollmar S, Wienhard K, Heiss WD (2003)
Improved herpes simplex virus type 1 ampli-
con vectors for proportional coexpression of
positron emission tomography marker and
therapeutic genes. Hum Gene Ther 14:
277-297
181. Boutell C, Canning M, Orr A, Everett RD
(2005) Reciprocal activities between herpes
simplex virus type 1 regulatory protein ICP0,
a ubiquitin E3 ligase, and ubiquitin-specifi c
protease USP7. J Virol 79:12342-12354
182. Lomonte P, Sullivan KF, Everett RD (2001)
Degradation of nucleosome-associated cen-
tromeric histone H3-like protein CENP-A
induced by herpes simplex virus type 1 pro-
tein ICP0. J Biol Chem 276:5829-5835
183. Cuchet D, Ferrera R, Lomonte P, Epstein AL
(2005) Characterization of antiproliferative
and cytotoxic properties of the HSV-1
immediate-early ICP0 protein. J Gene Med
7:1187-1199
184. Hoshi M, Harada A, Kawase T, Uyemura K,
Yazaki T (2000) Antitumoral effects of defec-
tive herpes simplex virus-mediated transfer of
tissue inhibitor of metalloproteinases-2 gene
in malignant glioma U87 in vitro: conse-
quences for anti-cancer gene therapy. Cancer
Gene Ther 7:799-805
185. Saydam O, Glauser DL, Heid I, Turkeri G,
Hilbe M, Jacobs AH, Ackermann M, Fraefel
C (2005) Herpes simplex virus 1 amplicon
vector-mediated siRNA targeting epidermal
growth factor receptor inhibits growth of
human glioma cells in vivo. Mol Ther
12:803-812
186. Ho IA, Hui KM, Lam PY (2004) Glioma-
specifi c and cell cycle-regulated herpes sim-
plex virus type 1 amplicon viral vector. Hum
Gene Ther 15:495-508
187. Ho IA, Hui KM, Lam PY (2006) Targeting
proliferating tumor cells via the transcrip-
tional control of therapeutic genes. Cancer
Gene Ther 13:44-52
188. Ho IA, Ng WH, Lam PY (2010) FasL and
FADD delivery by a glioma-specifi c and cell
cycle-dependent HSV-1 amplicon virus
enhanced apoptosis in primary human brain
tumors. Mol Cancer 9:270
189. Shah K, Tang Y, Breakefi eld XO, Weissleder R
(2003) Real-time imaging of TRAIL-induced
apoptosis of glioma tumors in vivo. Oncogene
22:6865-6872
Search WWH ::
Custom Search